{"id":"W3165573596","doi":"10.1136/annrheumdis-2021-eular.1856","title":"POS0220 INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"Medac; Gilead Sciences; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adverse effect; Rheumatoid arthritis; Internal medicine; Discontinuation; MedDRA; Adalimumab; Surgery; Pharmacovigilance","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009430094,0.0002752019,0.0008277518,0.0003157856,0.000184441,0.0008200887,0.0002546874,0.0004270961,0.00570051],"category_scores_gemma":[0.00143058,0.0001295627,0.0009692186,0.000388077,0.0001874302,0.0005686043,0.0002675823,0.001187213,0.001634782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003784665,"about_ca_system_score_gemma":0.0005161443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004412414,"about_ca_topic_score_gemma":0.0009738531,"domain_scores_codex":[0.9994692,0.0001514142,0.00005653941,0.00009524139,0.0001319047,0.00009561881],"domain_scores_gemma":[0.999428,0.0001619656,0.000162419,0.0000450048,0.0001105039,0.00009202991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1198772,0.002380113,0.09522976,0.002015391,0.002896011,0.001189359,0.0002296124,0.006730664,0.04104759,0.001188457,0.0166853,0.7105305],"study_design_scores_gemma":[0.02657989,0.1535061,0.5765407,0.001251983,0.0111456,0.01490038,0.0006231599,0.01253773,0.03030259,0.003058957,0.1692074,0.0003453603],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9452192,0.02724235,0.001196033,0.00113822,0.0002945271,0.0001525649,0.006390423,0.0001803278,0.01818624],"genre_scores_gemma":[0.9876521,0.003386865,0.0003664338,0.0008336568,0.0001568356,0.00008075538,0.004771038,0.00002552564,0.002726739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00570051,"threshold_uncertainty_score":0.01907009,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01330721115712947,"score_gpt":0.25851680106984,"score_spread":0.2452095899127105,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}